Where There’s a Will, There’s a Way
With less than a month to go until the SGX lists its new India derivative products, anything can happen. All eyes are on India’s regulator, Sebi, as well as the country’s three exchanges, to see what action—if any at all—they will take.
It just goes to show that if you’re determined enough, you will get your way. The case in point being the Singapore Exchange (SGX), which earlier in February this year was told that its data licenses with the National Stock Exchange of India (NSE) will no longer be available come August.
The NSE’s move, driven by its market regulator, the Securities and Exchange Board of India (Sebi), although sudden, was not altogether a big shock. Some market participants say that this could have been India’s
More on Regulation
Waters Wavelength
Wavelength Podcast Episode 165: Roman Ginis on Trade Execution
The founder and CEO of Imperative Execution looks at how trade execution is changing and what that means for the buy side.
Subscribe to Weekly Wrap emails
Most read
- Waters Rankings 2019: All the Winners
- Mizuho Finds New Ways to “Activate” its Data Using AI
- Barclays Nearly Finished with First Major Quantum Computing Experiment
- The AI Ethics Dilemma: Banks Find a Fine Line Between New Tech and 'What's Right'
- Finra to Expand Use of Machine Learning for Market Surveillance
Back to Top